Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

118 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Completed

Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia

NCT02124746

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • Scottsdale, Arizona, United States
  • Orange, California, United States
  • Stanford, California, United States
  • Whittier, California, United States
View all 22 locations
View Trial Details
Completed

A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms

NCT01387763

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Dept of Hematology, Aalborg hospital Aalborg, Denmark
  • Dept. of Hematology, Aarhus University Hospital Aarhus, Denmark
  • Dept of Hematology, Rigshospitalet Copenhagen, Denmark
  • Dept of Hematology, Esbjerg Hospital Esbjerg, Denmark
View Trial Details
Completed

A Phase 2 Study of RO7490677 In Participants With Myelofibrosis

NCT01981850

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Fibrosis, +11 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory Hospital Atlanta, Georgia, United States
  • University of Maryland Medical Center Baltimore, Maryland, United States
View all 23 locations
View Trial Details
Completed

Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy.

NCT02038036

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Antwerp, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 48 locations
View Trial Details
Completed

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

NCT03065400

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Phase Myelofibrosis, +9 more
Locations
  • Harvard Medical School Massachusetts General Hospital Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Montefiore Medical Center Division of Hematology, Department of Oncology The Bronx, New York, United States
View Trial Details

Related conditions